← Back to Screener
Scienture Holdings, Inc. Common Stock (SCNX)
Price$0.36
Value ScoreB
Growth ScoreB
Momentum ScoreD
Favorite Metrics
Price vs S&P 500 (26W)-47.84%
Price vs S&P 500 (4W)-9.99%
VGM Score52.82
Market Capitalization$14.63M
P/E Ratio (Annual)1.33x
All Metrics
Book Value / Share (Quarterly)$1.64
P/TBV (Annual)16.60x
Indicated Dividend (Annual)$0.00
Revenue Growth (3Y)-66.47%
Cash Flow / Share (Quarterly)$-0.33
Price vs S&P 500 (YTD)-37.57%
Gross Margin (TTM)97.23%
Net Profit Margin (TTM)-1084.44%
EPS (TTM)$-0.75
10-Day Avg Trading Volume0.29M
EPS Excl Extra (TTM)$-0.75
Revenue Growth (5Y)-52.10%
EPS (Annual)$-2.70
Dividend / Share (Annual)$3.08
ROI (Annual)-58.46%
Gross Margin (Annual)76.80%
Net Profit Margin (5Y Avg)-656.60%
Cash / Share (Quarterly)$0.09
Revenue Growth QoQ (YoY)449.03%
P/E Normalized (Annual)1.33x
ROA (Last FY)-49.31%
Revenue Growth TTM (YoY)340.01%
EBITD / Share (TTM)$-0.54
ROE (5Y Avg)-787.09%
Operating Margin (TTM)-1195.92%
Cash Flow / Share (Annual)$-0.33
P/B Ratio0.22x
P/B Ratio (Quarterly)0.17x
Net Income / Employee (Annual)$-10,378,100
EV / Revenue (TTM)18.21x
Net Interest Coverage (TTM)-28.32x
ROA (TTM)-14.21%
EPS Incl Extra (Annual)$-2.70
Current Ratio (Annual)2.89x
Quick Ratio (Quarterly)1.54x
3-Month Avg Trading Volume2.20M
52-Week Price Return-65.38%
Revenue / Employee (TTM)$161,600
Tangible BV / Share (Quarterly)$0.27
P/S Ratio (Annual)33.89x
Asset Turnover (Annual)0.01x
52-Week High$2.60
Operating Margin (5Y Avg)-4536.17%
EPS Excl Extra (Annual)$-2.70
CapEx CAGR (5Y)99.24%
26-Week Price Return-39.91%
Quick Ratio (Annual)2.72x
13-Week Price Return-10.45%
Total Debt / Equity (Annual)0.01x
Current Ratio (Quarterly)1.70x
Enterprise Value$11.77M
Revenue / Share Growth (5Y)-75.76%
Asset Turnover (TTM)0.01x
Revenue / Employee (Annual)$107,900
Inventory Turnover (Annual)21.74x
Pretax Margin (Annual)-10080.20%
Cash / Share (Annual)$0.16
3-Month Return Std Dev121.64%
Gross Margin (5Y Avg)35.48%
Net Income / Employee (TTM)$-3,432,500
ROE (Last FY)-59.20%
Net Interest Coverage (Annual)-7.77x
EPS Basic Excl Extra (Annual)$-2.70
P/FCF (TTM)3.46x
Receivables Turnover (TTM)1.78x
Total Debt / Equity (Quarterly)0.01x
EPS Incl Extra (TTM)$-0.75
Receivables Turnover (Annual)1.16x
ROI (TTM)-17.36%
P/S Ratio (TTM)22.63x
Pretax Margin (5Y Avg)-4802.80%
Revenue / Share (Annual)$0.03
Tangible BV / Share (Annual)$0.31
Price vs S&P 500 (52W)-89.75%
Year-to-Date Return-29.41%
5-Day Price Return-9.16%
EPS Normalized (Annual)$-2.70
ROA (5Y Avg)-73.75%
Net Profit Margin (Annual)-9618.00%
Month-to-Date Return-12.83%
EBITD / Share (Annual)$-2.80
Operating Margin (Annual)-9947.06%
LT Debt / Equity (Annual)0.00x
ROI (5Y Avg)-143.11%
LT Debt / Equity (Quarterly)0.00x
EPS Basic Excl Extra (TTM)$-0.75
P/TBV (Quarterly)2.86x
Payout Ratio (Annual)163.90%
P/B Ratio (Annual)0.30x
Dividend / Share (TTM)$0.25
Inventory Turnover (TTM)0.62x
Pretax Margin (TTM)-1084.44%
Book Value / Share (Annual)$1.73
Price vs S&P 500 (13W)-18.70%
Dividend Yield (TTM)14.96%
Beta3.03x
P/FCF (Annual)243.78x
Revenue / Share (TTM)$0.02
ROE (TTM)-18.12%
52-Week Low$0.24
vGradeB
gGradeB
mGradeD
vgmGradeC
Show chart for
Earnings Surprise History
Q1 26-0.08est. -0.22
Analyst Recommendations
Mar 2024
Mar 2026
Apr 2026
May 2026
4.14
4.14
4.14
4.14
Industry Peers — Pharmaceuticals(550)
| Symbol | Value Score | Growth Score | Momentum Score | Price |
|---|---|---|---|---|
SCNXScienture Holdings, Inc. Common Stock | B | B | D | $0.36 |
| LLYEli Lilly & Co. | D | B | B | $1131.42 |
| JNJJohnson & Johnson | D | C | B | $232.77 |
| ABBVABBVIE INC. | D | C | C | $227.23 |
| MRKMerck & Co., Inc. | C | C | B | $120.79 |
| NVSNovartis AG | C | C | C | $149.16 |
| AZNAstraZeneca PLC | D | B | C | $185.95 |
| NVONovo-Nordisk A/S | B | B | B | $42.96 |
| ABTAbbott Laboratories | C | C | D | $91.07 |
| PFEPfizer Inc. | B | C | C | $26.04 |
| BMYBristol-Myers Squibb Co. | B | C | B | $57.27 |
About
Scienture Holdings Inc develops specialty pharmaceutical products and healthcare services to address unmet market needs in the United States. The company emphasizes enhancing patient engagement and streamlining the prescription experience, delivering value to patients, caregivers, and providers.